As of May 23, 2025, the Sensus Healthcare stock's PE ratio is 42.64. This takes into account the latest EPS of $0.11 and stock price of $4.69. The PE ratio has grown by 105% from its last 4 quarters average of 20.8.
The PE ratio of Sensus Healthcare has averaged 20.47 over the last four years. The current P/E ratio of 42.64 is 108% higher than the historical average. Looking back at the last four years, SRTS's PE ratio peaked in the Dec 2023 quarter at 78.67, when the price was $2.36 and the EPS was $0.03. The lowest point was in the Dec 2022 quarter, when it reached 5.05 with a price of $7.42 and an EPS of $1.47.
Maximum annual increase: 1,457.82% in 2023
Maximum annual decrease: -82.51% in 2022
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
2024 | 16.88 | -78.54% | $6.92 | $0.41 |
2023 | 78.67 | 1,457.82% | $2.36 | $0.03 |
2022 | 5.05 | -82.51% | $7.42 | $1.47 |
2021 | 28.88 | N/A | $7.22 | $0.25 |
2020 | N/A | N/A | $3.86 | -$0.42 |
2019 | N/A | N/A | $3.54 | -$0.1 |
2018 | N/A | N/A | $7.41 | -$0.14 |
2017 | N/A | N/A | $5.16 | -$0.28 |
2016 | N/A | N/A | $5.25 | -$0.03 |
2015 | N/A | N/A | N/A | -$0.08 |
2014 | N/A | N/A | N/A | -$0.43 |
2013 | N/A | N/A | N/A | -$0.04 |
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
Mar 2025 | 43 | 154.74% | $4.73 | $0.11 |
Dec 2024 | 16.88 | 65.82% | $6.92 | $0.41 |
Sep 2024 | 10.18 | -21.69% | $5.8 | $0.57 |
Jun 2024 | 13 | -0.76% | $5.33 | $0.41 |
Mar 2024 | 13.1 | -83.35% | $3.8 | $0.29 |
Dec 2023 | 78.67 | N/A | $2.36 | $0.03 |
Sep 2023 | N/A | N/A | $2.77 | -$0.06 |
Jun 2023 | 22.5 | 59.8% | $3.15 | $0.14 |
Mar 2023 | 14.08 | 178.81% | $5.21 | $0.37 |
Dec 2022 | 5.05 | -35.09% | $7.42 | $1.47 |
Sep 2022 | 7.78 | 52.85% | $12.53 | $1.61 |
Jun 2022 | 5.09 | -35.65% | $7.68 | $1.51 |
Mar 2022 | 7.91 | -72.61% | $10.12 | $1.28 |
Dec 2021 | 28.88 | N/A | $7.22 | $0.25 |
Sep 2021 | N/A | N/A | $3.6 | -$0.02 |
The current PE ratio of SRTS is higher than its 3 and 5-year averages.
Stock name | PE ratio | Market cap |
---|---|---|
SRTS Sensus Healthcare Inc | 42.64 | $77.13M |
OBIO Orchestra BioMed Holdings Inc | N/A | $104.21M |
OM Outset Medical Inc | N/A | $318.12M |
As of May 23, 2025, SRTS stock has a price to earnings ratio of 42.64.
The 3-year average price to earnings ratio for SRTS stock is 20.85.
The 5-year average price to earnings ratio for SRTS stock is 20.47.
Over the last four years, the quarterly PE ratio reached its highest level at 78.67 in the Dec 2023 quarter.
SRTS's price to earnings ratio is currently 108% above its 4-year historical average.
To determine the P/E ratio, divide the latest stock price by the TTM earnings per share (EPS). As of today (May 23, 2025), Sensus Healthcare's share price is $4.69. The company's earnings per share for the trailing twelve months (TTM) ending Mar 2025 is $0.11. Therefore, Sensus Healthcare's PE ratio for today is 42.64. PE RATIO(42.64) = STOCK PRICE($4.69) / TTM EPS($0.11)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.